The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Menopause Treatment-Global Market Insights and Sales Trends 2024

Menopause Treatment-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1853919

No of Pages : 85

Ask Your Query

Synopsis

Menopause, also known as the climacteric, is the time in most women's lives when menstrual periods stop permanently, and they are no longer able to bear children. Menopause typically occurs between 49 and 52 years of age. Medical professionals often define menopause as having occurred when a woman has not had any vaginal bleeding for a year. It may also be defined by a decrease in hormone production by the ovaries. In those who have had surgery to remove their uterus but still have ovaries, menopause may be viewed to have occurred at the time of the surgery or when their hormone levels fell. Following the removal of the uterus, symptoms typically occur earlier, at an average of 45 years of age.

The global Menopause Treatment market size is expected to reach US$ 3050.4 million by 2029, growing at a CAGR of 2.4% from 2023 to 2029. The market is mainly driven by the significant applications of Menopause Treatment in various end use industries. The expanding demands from the Hospitals, Clinic and Others,, are propelling Menopause Treatment market. Hormonal Treatment, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-Hormonal Treatment segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Menopause Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Menopause Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Menopause Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Menopause Treatment sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Menopause Treatment covered in this report include Merck, Novartis, Novo Nordisk, Pfizer, Allergan, Emcure Pharmaceuticals, Eli Lilly And Company, Cipla and Teva Pharmaceutical Industries, etc.

The global Menopause Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Merck
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Allergan
  • Emcure Pharmaceuticals
  • Eli Lilly And Company
  • Cipla
  • Teva Pharmaceutical Industries

Global Menopause Treatment market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Menopause Treatment market, Segment by Type:

  • Hormonal Treatment
  • Non-Hormonal Treatment

Global Menopause Treatment market, by Application:

  • Hospitals
  • Clinic
  • Others

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Menopause Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Menopause Treatment
1.1 Menopause Treatment Market Overview
1.1.1 Menopause Treatment Product Scope
1.1.2 Menopause Treatment Market Status and Outlook
1.2 Global Menopause Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Menopause Treatment Market Size by Region (2018-2029)
1.4 Global Menopause Treatment Historic Market Size by Region (2018-2023)
1.5 Global Menopause Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Menopause Treatment Market Size (2018-2029)
1.6.1 North America Menopause Treatment Market Size (2018-2029)
1.6.2 Europe Menopause Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Menopause Treatment Market Size (2018-2029)
1.6.4 Latin America Menopause Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Menopause Treatment Market Size (2018-2029)
2 Menopause Treatment Market by Type
2.1 Introduction
2.1.1 Hormonal Treatment
2.1.2 Non-Hormonal Treatment
2.2 Global Menopause Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Menopause Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Menopause Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Menopause Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Menopause Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Menopause Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Menopause Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Menopause Treatment Revenue Breakdown by Type (2018-2029)
3 Menopause Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinic
3.1.3 Others
3.2 Global Menopause Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Menopause Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Menopause Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Menopause Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Menopause Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Menopause Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Menopause Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Menopause Treatment Revenue Breakdown by Application (2018-2029)
4 Menopause Treatment Competition Analysis by Players
4.1 Global Menopause Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Menopause Treatment as of 2022)
4.3 Date of Key Players Enter into Menopause Treatment Market
4.4 Global Top Players Menopause Treatment Headquarters and Area Served
4.5 Key Players Menopause Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Menopause Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck
5.1.1 Merck Profile
5.1.2 Merck Main Business
5.1.3 Merck Menopause Treatment Products, Services and Solutions
5.1.4 Merck Menopause Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Merck Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Menopause Treatment Products, Services and Solutions
5.2.4 Novartis Menopause Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis Recent Developments
5.3 Novo Nordisk
5.3.1 Novo Nordisk Profile
5.3.2 Novo Nordisk Main Business
5.3.3 Novo Nordisk Menopause Treatment Products, Services and Solutions
5.3.4 Novo Nordisk Menopause Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Menopause Treatment Products, Services and Solutions
5.4.4 Pfizer Menopause Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 Allergan
5.5.1 Allergan Profile
5.5.2 Allergan Main Business
5.5.3 Allergan Menopause Treatment Products, Services and Solutions
5.5.4 Allergan Menopause Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Allergan Recent Developments
5.6 Emcure Pharmaceuticals
5.6.1 Emcure Pharmaceuticals Profile
5.6.2 Emcure Pharmaceuticals Main Business
5.6.3 Emcure Pharmaceuticals Menopause Treatment Products, Services and Solutions
5.6.4 Emcure Pharmaceuticals Menopause Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Emcure Pharmaceuticals Recent Developments
5.7 Eli Lilly And Company
5.7.1 Eli Lilly And Company Profile
5.7.2 Eli Lilly And Company Main Business
5.7.3 Eli Lilly And Company Menopause Treatment Products, Services and Solutions
5.7.4 Eli Lilly And Company Menopause Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Eli Lilly And Company Recent Developments
5.8 Cipla
5.8.1 Cipla Profile
5.8.2 Cipla Main Business
5.8.3 Cipla Menopause Treatment Products, Services and Solutions
5.8.4 Cipla Menopause Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Cipla Recent Developments
5.9 Teva Pharmaceutical Industries
5.9.1 Teva Pharmaceutical Industries Profile
5.9.2 Teva Pharmaceutical Industries Main Business
5.9.3 Teva Pharmaceutical Industries Menopause Treatment Products, Services and Solutions
5.9.4 Teva Pharmaceutical Industries Menopause Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Teva Pharmaceutical Industries Recent Developments
6 North America
6.1 North America Menopause Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Menopause Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Menopause Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Menopause Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Menopause Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Menopause Treatment Market Dynamics
11.1 Menopause Treatment Industry Trends
11.2 Menopause Treatment Market Drivers
11.3 Menopause Treatment Market Challenges
11.4 Menopause Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock